To determine PI3K-AKT signaling outcomes under the competing influences of influenza and alpelisib, we measured pAKT activity in cells pre-treated with increasing concentrations of alpelisib and then infected with either CA09 or TX12. The gene discussed is AKT1; the disease is influenza.